[Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency]. 2010

Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
Inserm Unité 575 Physiopathologie du système nerveux central, Institut de virologie, Strasbourg, France. schwartz.christian@iutlpa-strasbg.fr

The introduction of the highly active antiretroviral therapy (HAART) in 1996 has greatly extended survival and raised hopes for the eradication of HIV-1. Unfortunately, the optimism declined by revealing the existence of latent HIV-1 reservoirs in cells targeted by the virus. The long-lived HIV-1 reservoirs constitute a major obstacle to the eradication of HIV-1. Understanding the molecular mechanisms of virus latency is essential for efficient therapeutic intervention against the virus.

UI MeSH Term Description Entries
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014158 Transcription, Genetic The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION. Genetic Transcription
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015967 Gene Expression Regulation, Viral Any of the processes by which cytoplasmic factors influence the differential control of gene action in viruses. Regulation of Gene Expression, Viral,Viral Gene Expression Regulation,Regulation, Gene Expression, Viral
D016662 Virus Integration Insertion of viral DNA into host-cell DNA. This includes integration of phage DNA into bacterial DNA; (LYSOGENY); to form a PROPHAGE or integration of retroviral DNA into cellular DNA to form a PROVIRUS. Integration, Provirus,Integration, Virus,Provirus Integration,Viral integration,Integrations, Provirus,Integrations, Virus,Provirus Integrations,Viral integrations,Virus Integrations,integration, Viral,integrations, Viral
D017628 Microglia The third type of glial cell, along with astrocytes and oligodendrocytes (which together form the macroglia). Microglia vary in appearance depending on developmental stage, functional state, and anatomical location; subtype terms include ramified, perivascular, ameboid, resting, and activated. Microglia clearly are capable of phagocytosis and play an important role in a wide spectrum of neuropathologies. They have also been suggested to act in several other roles including in secretion (e.g., of cytokines and neural growth factors), in immunological processing (e.g., antigen presentation), and in central nervous system development and remodeling. Microglial Cell,Cell, Microglial,Microglial Cells,Microglias

Related Publications

Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
January 2012, Advances in virology,
Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
October 2005, Expert review of anti-infective therapy,
Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
January 1991, Postepy biochemii,
Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
February 2016, Trends in microbiology,
Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
January 2023, Frontiers in cellular and infection microbiology,
Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
February 2016, The Journal of clinical investigation,
Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
May 2007, Cancer treatment reviews,
Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
January 1990, Biorheology,
Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
January 1984, Critical care nurse,
Christian Schwartz, and Valentin Le Douce, and Thomas Cherrier, and Laetitia Redel, and Céline Marban, and Dominique Aunis, and Olivier Rohr
January 2002, Clinical journal of oncology nursing,
Copied contents to your clipboard!